|
Market Cap (4-Jul) $65,341,640 (532nd) |
Close (30-Jun) $0.78 |
Volume (30-Jun) 230,813 |
Shortsold (19-Jun) 25,352 (0.02%) (510th) |
|
52w High $0.94 |
52w Low $0.385 |
P/E 166.67 |
EPS -0.34 |
MVP released this announcement to the ASX on 3 March 2022, 8:37. The announcement is marked as price sensitive, and is 6 page(s) in length and 555.79kb in size.
You can view all announcements from MVP and see how they appear on a price chart on the announcements page.
At the date of this announcement, MVP was 0.623% short sold according to ASIC data. It was ranked the 258th most shorted stock on the ASX. It remains ranked 510th as of the latest reported data (19 June 2025).
| Other Recent Announcements from MVP | |
|---|---|
| Change in substantial holding | 15 May 2023, 16:59 |
| Final Director's Interest Notice - D. Williams | 26 April 2023, 14:29 |
| Resignation of Director | 18 April 2023, 9:18 |
| US FDA Investor Presentation | 3 March 2022, 8:37 |
| Green Whistle gets the Green Light - FDA Clears US Trial | 2 March 2022, 10:18 |
| Trading Halt | 1 March 2022, 9:34 |
| MVP FY22 Half Year Investor Presentation | 24 February 2022, 17:01 |
You must be logged in to post a reply.
Medical Developments International 